Global Serum Free Media Market Report and Forecast 2023-2031
Global Serum Free Media Market Outlook
The growth of the global serum free media market size is being driven by the increasing demand for cell-based vaccines across the globe. The market attained a value of USD 1.43 billion in 2022. The market is anticipated to grow at a CAGR of 10.04% during the forecast period of 2023-2031 to attain a value of USD 3.37 by 2031.
SFM offers several advantages over serum-containing media, including batch-to-batch consistency, reduced risk of contamination by adventitious agents, and improved control over the quality and quantity of the product being produced. Additionally, the use of SFM can reduce the ethical concerns and variability associated with the use of animal serum in cell culture.
Overall, the use of SFM has become increasingly popular in the biopharmaceutical industry and it is expected to continue to grow in the coming years
North America is expected to dominate the market due to the presence of well-established pharmaceutical and biotechnology industries, as well as significant investments in R&D activities. The Asia-Pacific region is also expected to witness significant growth during the forecast period due to increasing investments in biotechnology and pharmaceutical sectors, rising demand for biologics, and growing government initiatives to support the development of the healthcare industry.
This product will be delivered within 5-7 business days.
Global Serum Free Media Market Outlook
The growth of the global serum free media market size is being driven by the increasing demand for cell-based vaccines across the globe. The market attained a value of USD 1.43 billion in 2022. The market is anticipated to grow at a CAGR of 10.04% during the forecast period of 2023-2031 to attain a value of USD 3.37 by 2031.
Serum Free Media: Introduction
Serum-free media (SFM) are cell culture media formulated without the use of animal serum or serum-derived components. Instead, SFM relies on defined components and growth factors that are chemically defined or derived from non-animal sources. SFM is widely used in the biopharmaceutical industry for the production of therapeutic proteins, vaccines, and other biologics.SFM offers several advantages over serum-containing media, including batch-to-batch consistency, reduced risk of contamination by adventitious agents, and improved control over the quality and quantity of the product being produced. Additionally, the use of SFM can reduce the ethical concerns and variability associated with the use of animal serum in cell culture.
Overall, the use of SFM has become increasingly popular in the biopharmaceutical industry and it is expected to continue to grow in the coming years
Global Serum Free Media: Application and Uses
Serum-free media (SFM) are cell culture media formulated without animal-derived serum. SFMs have been developed to overcome the problems associated with serum-based media, such as contamination, lot-to-lot variation, and the potential presence of xenogeneic antigens, viruses, and prions. SFMs are used in various applications such as in vitro fertilization, stem cell research, monoclonal antibody production, vaccine production, and gene therapy. They are also used for the production of recombinant proteins and antibodies, particularly for biopharmaceuticals. SFMs have also found application in tissue engineering and regenerative medicine, particularly in the development of cell-based therapies.Global Serum Free Media: Market Segmentations
Market Breakup by Media Type
- Protein Expression Media
- Stem Cell Media
- Hybridoma Media
- Primary Cell Media
- Insect Cell Media
- Immunology Media
- CHO Cell Culture
- Chemically Defined
- Others
Market Breakup by End User
- Biopharmaceutical Companies
- Clinical Research Organisations
- Academic Research Centres
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Global Serum Free Media Market Scenario
The increasing demand for cell-based vaccines and rising adoption of serum-free media in research and development activities are the major factors driving the growth of the market. In addition, the advantages of serum-free media over traditional serum-based media, such as reduced risk of contamination and batch-to-batch variability, are also contributing to the growth of the market.North America is expected to dominate the market due to the presence of well-established pharmaceutical and biotechnology industries, as well as significant investments in R&D activities. The Asia-Pacific region is also expected to witness significant growth during the forecast period due to increasing investments in biotechnology and pharmaceutical sectors, rising demand for biologics, and growing government initiatives to support the development of the healthcare industry.
Key Players in the Global Serum Free Media Market
The report gives an in-depth analysis of the key players involved in the global serum free media market. The companies included in the market are as follows:- Lonza
- Corning Incorporated
- Nippon Genetics Co. Ltd
- MP Biomedicals LLC
- Danaher Corporation
- PromoCell GmbH
- Thermo Fisher Scientific, Inc
- FUJIFILM Holdings Corporation
- Illumina, Inc
- Sigma Aldrich
- HiMedia Laboratories
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Global Serum Free Media Market Overview
4 Global Serum Free Media Market Landscape
5 Global Serum Free Media Market Dynamics
6 Global Serum Free Media Market Segmentation
7 North America Serum Free Media Market
8 Europe Serum Free Media Market
9 Asia Pacific Serum Free Media Market
10 Latin America Serum Free Media Market
11 Middle East and Africa Serum Free Media Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Serum Free Media Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Lonza
- Corning Incorporated
- Nippon Genetics Co. Ltd.
- Mp Biomedicals LLC
- Danaher Corporation
- Promocell GmbH
- Thermo Fisher Scientific, Inc.
- Fujifilm Holdings Corporation
- Illumina, Inc.
- Sigma Aldrich
- Himedia Laboratories
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 147 |
Published | April 2023 |
Forecast Period | 2023 - 2031 |
Estimated Market Value ( USD | $ 1.57 Billion |
Forecasted Market Value ( USD | $ 3.37 Billion |
Compound Annual Growth Rate | 10.0% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |